Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05243069 · ClinicalTrials.gov registry record · NA
Head and Neck Cancer Patient Symptom and Oncologic Outcomes
A NA study of Lymphedema of the Head and Neck, sponsored by Ohio State University Comprehensive Cancer Center.
- Recruiting
- Registry status
- NA
- Development phase
- 80
- Enrollment target
- 1
- Study location
NCT05243069 is a NA study of Lymphedema of the Head and Neck that is actively recruiting participants, run by Ohio State University Comprehensive Cancer Center. The registered enrollment target is 80 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05243069, a NA study of Lymphedema of the Head and Neck, is actively recruiting participants, sponsored by Ohio State University Comprehensive Cancer Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
This trial investigates a new approach using a mobile three-dimensional (3D) scanning application for volumetric measurement of the head and neck region in patients with head and neck lymphedema. Lymphedema is the buildup of extra lymph fluid in tissues that causes swelling. Accurate volumetric measurements of swelling are crucial to the diagnosis of lymphedema and to monitoring response to therapy and disease progression over time. A mobile 3D surface scanning application may help doctors measure and analyze swelling in patients with head and neck lymphedema.
Conditions Studied
Interventions
- PROCEDURE Imaging Technique
Study Locations (1)
Ohio
- Ohio State University Comprehensive Cancer Center - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2023-03-31 |
| Est. Completion | 2028-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05243069
The ClinicalTrials.gov registry entry for NCT05243069 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University Comprehensive Cancer Center, which has 341 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Lymphedema of the Head and Neck appearing as the primary indexed condition, and to 1 intervention - of which Imaging Technique is the first listed.
NCT05243069 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT05243069 about?
NCT05243069 is a clinical study titled "Head and Neck Cancer Patient Symptom and Oncologic Outcomes". This trial investigates a new approach using a mobile three-dimensional (3D) scanning application for volumetric measurement of the head and neck region in patients with head and neck lymphedema. Lymphedema is the buildup of extra lymph fluid in tissues that causes swelling. Accurate volumetric meas...
What is the current status of trial NCT05243069?
This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2023-03-31. Estimated completion is 2028-12-31.
What conditions does trial NCT05243069 study?
This clinical trial studies the following conditions: Lymphedema of the Head and Neck.
What interventions are being tested in trial NCT05243069?
The interventions under investigation include: Imaging Technique (PROCEDURE).
Who is sponsoring clinical trial NCT05243069?
This trial is sponsored by Ohio State University Comprehensive Cancer Center, which has 341 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05243069 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lymphedema of the Head and Neck
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.